NORML

APRIL 30, 2020

CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.” ” Among pain patients enrolled in medical cannabis access programs, most subjects report eventually decreasing or even eliminating their use of opiates.

Chronic Pain 340

Chronic Pain Clinical Trials Data Patients 340

United Patients Group

JANUARY 30, 2023

The Benefits of Cannabis in the Treatment of Myasthenia Gravis Introduction Myasthenia gravis ( MG ) is a rare autoimmune disease that affects the nerves and muscles. Doctors usually treat MG with thymectomies, immunomodulating drugs, acetylcholinesterase inhibitors and IV immunoglobulin treatments. Could marijuana be the answer?

Treatment 134

Treatment Cannabinoids Blood Pressure Patients 134

Cannabis Law Report

MARCH 26, 2021

Patients have run out of patience: “We don’t have access to treatment, cannabis is an urgency” Source: [link] We publish… Read More.

Treatment 98

Treatment Access Patients Cannabis 98

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “This year, my focus was on program improvements to further expand both access and therapeutic value to benefit the health and well-being of all Virginians.”

Law 257

Law Patients Access Oil 257

MMJ Recs

DECEMBER 10, 2023

While some states have embraced the therapeutic potential of cannabis and established robust medical marijuana programs, others lag behind, leaving patients without access to a potentially life-changing treatment. Disparities in access are primarily driven by the differing state regulations and policies surrounding medical marijuana.

Access 97

Access Marijuana Treatment Patients 97

Veriheal

JANUARY 15, 2024

Active research was carried out on the effects of these drug policies on society and the results, in these reports, have led the United Nations to consider a favorable revision of drug policies in order to protect human rights. 2023 World UN World Drug Report The 2023 World Drug Report urges the development of effective drug policies.

Policy 119

Policy Research and Development Collective Law 119

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access.

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

AUGUST 20, 2021

The MS Society has said that thousands of multiple sclerosis patients are being denied access to the approved drug Sativex, which helps improve spasm symptoms in sufferers. Many are finding that despite the treatment being approved, they are being denied access in their area.”. How much longer are we going to have to wait?

Access 105

Access Patients Media Treatment 105

Canna Care Docs

MARCH 27, 2025

This trend raises important questions about access, affordability, and the future of medical cannabis as a vital healthcare resource. The program aimed to provide safe, legal access to cannabis for patients with chronic conditions. This decrease has raised concerns about access to cannabis-based treatments for those who need them most.

Programs 52

Programs Recreational Dispensary Patients 52

NORML

JANUARY 19, 2020

The US House Energy and Commerce Subcommittee on Health will hold a legislative hearing entitled “Cannabis Policies for the New Decade.” ” This marks the first time that members of the Energy and Commerce Committee will hear and debate issues specific to marijuana policy reform. IN resident? NH resident? NJ resident?

Legislation 251

Legislation Decriminalization Access Patients 251

Cannabis Law Report

JULY 28, 2021

president and CEO of MJH Life Sciences™, parent company of Cannabis Patient Care ™ “We are thrilled to partner with Americans for Safe Access because we share their passion for education and for helping as many patients as we can.”.

Access 81

Access Patients Education Treatment 81

Cannabis Law Report

MARCH 3, 2020

In Indianapolis on January 29, a quiet, eager audience of nurses give their rapt attention to Jason Straw as he takes center stage at the 2020 ISNA Policy Conference. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. PURPOSE : .

Policy 81

Policy Research and Development Chronic Pain Cannabinoids 81

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

CannaMD

MARCH 19, 2020

As Florida’s leading medical cannabis physicians , CannaMD is committed to working closely with licensed dispensaries to ensure medical cannabis patients stay safe while continuing uninterrupted treatment during the coronavirus (COVID-19) crisis. UPDATE (3/19): MEDICAL MARIJUANA PHYSICIAN APPOINTMENTS. COLUMBIA CARE.

Policy 98

Policy Dispensary Patients Safety 98

NORML

MARCH 7, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. Legislation is pending that would expand the pool of individuals eligible for medical cannabis access. GA resident? MN resident?

Legislation 252

Legislation Decriminalization Patients THC 252

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

NORML

FEBRUARY 23, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. Send a message to your lawmakers in support of medical marijuana access. AL resident? VA resident? West Virginia.

Legislation 252

Legislation Patients Decriminalization Access 252

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. For example, the Tuskegee Syphilis Study, wherein Black men were deceived regarding their diagnosis and deprived appropriate treatment over the course of decades.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Cannabis Chronicles

MAY 22, 2019

The partnership between the land grant institution in Pullman and the Tacoma-based native tribe is intended to create a standard to evaluate treatment plans at a natural healing clinic the Puyallups opened in October, and to determine the effectiveness of the drug as an alternative to opioids in managing pain.

Medicine 140

Medicine Research and Development Data Collective 140

NORML

MARCH 14, 2019

This conflict between state and federal laws limits treatment options and federal employment opportunities, particularly impacting veterans who comprise approximately one-third of the federal workforce and whose medical cannabis use to treat chronic pain and PTSD has been found to be double the rate of the general public.

Chronic Pain 205

Chronic Pain Legislation Treatment State Laws 205

The Cannigma

MARCH 25, 2021

A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Veriheal

JULY 7, 2021

Because, now that they finally have legal access to cannabis, these patients will be able to use cannabis to treat their pain , anxiety , sleep disruption , and more. Following every cannabis policy change that broadens cannabis access, thousands more prospective patients gain the right to use cannabis.

Legalization 119

Legalization Access Policy Chronic Pain 119

Project CBD

NOVEMBER 11, 2023

And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. Dr. Weil: The greater the potential of a treatment to cause harm, the stricter the standards of evidence it should be held to for efficacy. Dr. Weil: In most U.S.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Psilocybin Policies Around the Nation Let’s explore where psilocybin is legal, decriminalized, and on the ballot across U.S. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Veriheal

MARCH 27, 2025

With Nelson promising to lower product costs if the bill is passed, it would make medical cannabis more affordable and accessible for patients. The board created policy recommendations , including licensing more state dispensaries, exempting medical cannabis products from sales tax, and providing more oversight on telehealth providers.

Chronic Pain 52

Chronic Pain Patients THC Programs 52

MMJ Recs

MAY 1, 2024

Through community outreach, social media campaigns, educational seminars, and mental health screenings, the month seeks to empower individuals to seek help when needed, cultivate supportive environments, and advocate for policies that promote mental health equity and access to care.

Marijuana 105

Marijuana Treatment Conditions Chronic Pain 105

SpeedWeed

MAY 7, 2021

Colorado Governor Jared Polis just signed a bill that will make it easier for students to access medical cannabis while in school. . This legislation will allow students access to life-saving epilepsy treatments and other essential medicines, but still prohibits smokable cannabis on school property. View original article.

Access 52

Access Law Marijuana Policy 52

Veriheal

DECEMBER 4, 2023

Let’s take a look at how businesses are parting ways with traditional “cannabis tests” as well as how legal access leads to fair employment opportunities for consumers alike. With the “green wave” gaining momentum, our perceptions and policies concerning cannabis are on the verge of historic change.

Policy 119

Policy Safety Treatment Business 119

Cannabis Law Report

FEBRUARY 12, 2023

Join this FREE, 75-minute online webinar to gain access to insights and learn about ground-breaking treatments to chronic mental health conditions. FREE WEBINAR: Helping to change policy – Influencing the TGA with Professor David Nutt (UK) What we know, what we think, and what we need to research Psychedelic […]

Policy 52

Policy Medicine Events Treatment 52

Cannabis Law Report

JUNE 21, 2021

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Access to treatment. Daniel Perkins a b Hugh Brophy a Iain S. Background. Conclusion.

Medicine 45

Medicine Safety Policy Treatment 45

Cannabis Law Report

JUNE 12, 2021

Recent shifting attitudes towards the medical use of cannabis has seen legal access pathways established in many jurisdictions in North America, Europe and Australasia. Here we undertake an analysis of this policy issue based on a case study of the introduction of medicinal cannabis in Australia. Background. Conclusion.

Policy 51

Policy Safety Medicine Access 51

Cannabis Law Report

AUGUST 7, 2022

There is a rapidly growing movement to create safe access to psychedelic medicines. The Microdosing Collective (“Microdosing Collective” or “the Collective”) is a new initiative supporting education around regulatory policy to permit legal microdosing for optimal wellbeing. We seek to change that.”.

Microdosing 52

Microdosing Collective Access Education 52

Cannabis Law Report

SEPTEMBER 9, 2021

The current public policies in local and state cannabis ordinance and equity programs may enhance racial disparities if they follow the pattern of exclusion and criminalization that encompass past policies promoted as beneficial to African Americans but uphold racial capitalistic practices. Theme 3 involved access to capital.

Policy 105

Policy Research and Development Collective Banking 105

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

FEBRUARY 27, 2020

In order to contribute concretely in shaping future EU policies, EAMC is currently working with its members on a medicinal cannabis manifesto, which will identify regulatory solutions that could be implemented by European policymakers.

Law 102

Law Medicine Compliance Compliance 102

NORML

FEBRUARY 22, 2019

Legislation is pending, Senate Bill 305, to permit qualified patients the ability to access medical cannabis preparations while in health care facilities. Click here to email your lawmakers in support of access in healthcare facilities. Click here to email your lawmakers in support of banking access. California. CA resident?

Legislation 192

Legislation Hemp Compliance Compliance 192

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Access to Psychedelic Therapies and Equity in Emerging Psychedelics Industries. Background.

Law 59

Law Policy Research and Development Clinical Trials 59